{"id":966170,"date":"2026-05-21T18:14:41","date_gmt":"2026-05-21T22:14:41","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/"},"modified":"2026-05-21T18:14:41","modified_gmt":"2026-05-21T22:14:41","slug":"first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/","title":{"rendered":"First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN DIEGO, Calif., May  21, 2026  (GLOBE NEWSWIRE) &#8212; First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that Daniel Faga, president and chief executive officer, and\/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences:<\/p>\n<p>\n        <strong>2026 Jefferies Global Healthcare Conference, New York<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Format \u2013 Presentation and one-on-one investor meetings<\/li>\n<li>Date and Time \u2013 Wednesday, June 3, 2026 at 12:15pm ET \/ 9:15am PT\n<\/li>\n<\/ul>\n<p>\n        <strong>Leerink Partners Therapeutics Forum, Boston<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Format \u2013 One-on-one investor meetings<\/li>\n<li>Date and Time \u2013 Tuesday, July 14, 2026\n<\/li>\n<\/ul>\n<p>A live webcast of the presentation will be available on the investor section of the First Tracks website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4nR82Mfzaky-jXzOfboL2hyOEkyvY-EFviEfIMPc8e-SIvi8VrqnF7GQtZ_CPTGbUxGZ0OaMvKiD0z6H6EfGwqwgsvvnSSufDSVWuLSj0OO6-uqQ7xEStqSUwyu1OR5irPsOSFW8ykQwAz1e9fp13SUbOTLUBIxUV6Frvz4q5nU=\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.firsttracksbio.com\/news-events\/events<\/a>. A replay of the webcast will be available for at least 30 days following the event.<\/p>\n<p>\n        <strong>About First Tracks Biotherapeutics<\/strong>\n      <\/p>\n<p>First Tracks Biotherapeutics is a clinical stage biotechnology company advancing antibody therapies that modulate immune pathways implicated in autoimmune and inflammatory diseases. Its pipeline includes ANB033, a CD122 antagonist in development for celiac disease and eosinophilic esophagitis; rosnilimab, a pathogenic T cell depleter in development for rheumatoid arthritis; and ANB101, a BDCA2 modulator. To learn more, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UAe9fAWjkOzlsmIZcPAZsCqJDuVtYJVcHJ_7BXK5OYbjiuxcJiOFzRxT_Uqyw6MWILX1YcdoSDLelJDqTXxlXqPuh2lr9OibiYrWcuyNfHQ=\" rel=\"nofollow\" target=\"_blank\">www.FirstTracksBio.com<\/a> or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=73Y_ZUsBvGwszqld5TR-2NIPtxTujzG0muK2j45Rs_7VkHDkD2rL7Dm2I4xtNvx-2jZWNjiO0sX2KUI4fzdGCcd2WdG5_2LyMwudhbVS-OekAWMXnHma0ZEbSXscsSq1\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Nick Montemarano<br \/>Executive Director, Investor Relations<br \/>858.732.0178<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ju_lb1GoppRggkxU0DaNFayVuUNkxoKy7w-iJGd9RJ0s62l1YqYvfBk5HqGa17pCvb--s21vodDaQGRa4oF16jesu9ad559ZTgRlN0IfLyLmMVKhsUzWN45bLMm6QBzp\" rel=\"nofollow\" target=\"_blank\">investors@firsttracksbio.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDg1MiM3NjE2MTg0IzIzMDk5ODg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTQzMmI3N2QtNmRiNC00MzdkLThmODktZjRiNzZjYTQ2ZDY1LTEzMjE1MzgtMjAyNi0wNS0yMS1lbg==\/tiny\/First-Tracks-Biotherapeutics-I.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Calif., May 21, 2026 (GLOBE NEWSWIRE) &#8212; First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that Daniel Faga, president and chief executive officer, and\/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences: 2026 Jefferies Global Healthcare Conference, New York Format \u2013 Presentation and one-on-one investor meetings Date and Time \u2013 Wednesday, June 3, 2026 at 12:15pm ET \/ 9:15am PT Leerink Partners Therapeutics Forum, Boston Format \u2013 One-on-one investor meetings Date and Time \u2013 Tuesday, July 14, 2026 A live webcast of the presentation will be available on the investor section of the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-966170","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Calif., May 21, 2026 (GLOBE NEWSWIRE) &#8212; First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that Daniel Faga, president and chief executive officer, and\/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences: 2026 Jefferies Global Healthcare Conference, New York Format \u2013 Presentation and one-on-one investor meetings Date and Time \u2013 Wednesday, June 3, 2026 at 12:15pm ET \/ 9:15am PT Leerink Partners Therapeutics Forum, Boston Format \u2013 One-on-one investor meetings Date and Time \u2013 Tuesday, July 14, 2026 A live webcast of the presentation will be available on the investor section of the &hellip; Continue reading &quot;First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-21T22:14:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDg1MiM3NjE2MTg0IzIzMDk5ODg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences\",\"datePublished\":\"2026-05-21T22:14:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\\\/\"},\"wordCount\":222,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNDg1MiM3NjE2MTg0IzIzMDk5ODg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\\\/\",\"name\":\"First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNDg1MiM3NjE2MTg0IzIzMDk5ODg=\",\"datePublished\":\"2026-05-21T22:14:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNDg1MiM3NjE2MTg0IzIzMDk5ODg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNDg1MiM3NjE2MTg0IzIzMDk5ODg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences - Market Newsdesk","og_description":"SAN DIEGO, Calif., May 21, 2026 (GLOBE NEWSWIRE) &#8212; First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that Daniel Faga, president and chief executive officer, and\/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences: 2026 Jefferies Global Healthcare Conference, New York Format \u2013 Presentation and one-on-one investor meetings Date and Time \u2013 Wednesday, June 3, 2026 at 12:15pm ET \/ 9:15am PT Leerink Partners Therapeutics Forum, Boston Format \u2013 One-on-one investor meetings Date and Time \u2013 Tuesday, July 14, 2026 A live webcast of the presentation will be available on the investor section of the &hellip; Continue reading \"First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-21T22:14:41+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDg1MiM3NjE2MTg0IzIzMDk5ODg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences","datePublished":"2026-05-21T22:14:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/"},"wordCount":222,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDg1MiM3NjE2MTg0IzIzMDk5ODg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/","name":"First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDg1MiM3NjE2MTg0IzIzMDk5ODg=","datePublished":"2026-05-21T22:14:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDg1MiM3NjE2MTg0IzIzMDk5ODg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDg1MiM3NjE2MTg0IzIzMDk5ODg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/first-tracks-biotherapeutics-announces-participation-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/966170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=966170"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/966170\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=966170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=966170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=966170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}